Impact of a simple regimen of low molecular weight heparin (reviparin) in preventing mortality, reinfarction, and strokes in over 15,500 patients with ST-elevation acute myocardial infarction: The CREATE trial Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

publication date

  • February 1, 2005